Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 173
Selected: 0
NCT IDTitle
NCT01000129Adaptive Planning in Bladder Cancer
NCT06126731Combination Study of Antibiotics With Enzalutamide (PROMIZE)
NCT03327662Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer
NCT00532727Triple Negative Breast Cancer Trial
NCT05375591AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
NCT00022191Cisplatin Plus Gemcitabine With or Without Paclitaxel in Treating Patients With Stage IV Urinary Tract Cancer
NCT066302605G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
NCT06423976Microbiome Molecular Charaterisation
NCT01476462Second Malignant Neoplasms After Childhood ALL Therapy
NCT05097274The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
NCT03875820Phase I Trial of Defactinib and VS-6766.
NCT02541266Imaging in Clinical Trials - a Questionnaire Study to Assess Impact of Imaging Regimes on Patient Participation
NCT00499174Observation or Radical Treatment in Patients With Prostate Cancer
NCT06636526The I4i PRODICT™ Study: Evaluation of the I4i PRODICT™ Test in Different Ethnic Groups (The I4i PRODICT™ Study).
NCT04985266A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer
NCT02955082The BARCODE 2 Study - the Use of Genetic Profiling to Guide Prostate Cancer Treatment
NCT00140582Primary Rituximab and Maintenance
NCT00002582Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
NCT04117594Whole Body Magnetic Resonance Imaging Study
NCT02437227A Phase I, First in Man Study to Evaluate the Safety and Tolerability of a panRAF Inhibitor (CCT3833/BAL3833)in Patients With Solid Tumours
NCT02380027PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?
NCT02429427European Celecoxib Trial in Primary Breast Cancer
NCT011246823-Dimensional Conformal Radiation Therapy in Treating Patients With Bladder Cancer Who Have Undergone Transurethral Resection of the Bladder
NCT01726374Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours
NCT01331525The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT00301925Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery
NCT01505829Diffusion-weighted Imaging Study in Cancer of the Ovary
NCT01337401A Trial of Cediranib in the Treatment of Patients With Alveolar Soft Part Sarcoma (CASPS)
NCT02998567Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
NCT00814567Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery
NCT01332968A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
NCT02525068A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC
NCT00077168Adjuvant Radiation Therapy Compared With Observation After Surgery in Treating Women With Estrogen Receptor Positive or Progesterone Receptor Positive Ductal Carcinoma In Situ of the Breast Who Are Receiving Tamoxifen or Anastrozole
NCT03158922The BARCODE 1 Pilot Study
NCT02338310Trial of Perioperative Endocrine Therapy - Individualising Care
NCT01658930Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
NCT01810757Study of Weekly Radiotherapy for Bladder Cancer
NCT02388230Quantification of Breast RadioTherapy Associated Late Toxicity Using Novel UltraSound Techniques
NCT00253422Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
NCT00079248Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT03307148Stromal TARgeting for PAncreatic Cancer (STAR_PAC)
NCT01881386Lactate Imaging as a Tumour Biomarker
NCT00392535Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer
NCT01693822A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy
NCT02338622Trial of Olaparib in Combination with AZD5363 (ComPAKT)
NCT05968417Myeloma Novel Drug Discovery Ver 1.2
NCT04763317Precision Medicine in the Prostate Cancer Care Pathway
NCT02705846Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations
NCT02296801A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer